An estimated 168,000 Americans live with metastatic breast cancer. While treatments exist, there is no cure. And with average five-year survival rates at just 29%, time is a privilege many […]
This author has not written his bio yet.
But we are proud to say that MBCA contributed 38 entries already.
Entries by MBCA
New collaboration will target dormant tumor cells, keeping them asleep (or killing them) so they won’t spread. Translational breast cancer researcher Dr. Cyrus Ghajar, epidemiologist Dr. Christopher Li, and immunotherapy expert […]
New clinical trial results could open the door to more effective treatments for about half of all people with metastatic breast cancer—those whose tumors don’t have high levels of the […]